📖
TP53 mutations drive therapy resistance through post-mitochondrial caspase blockade.
Mamdouh AM, Iftikhar F, Olesinski EA, Lim FQ, Jasdanwala S, Wang Y, Mi Y, Lin NSE, Liang DTE, Chowdhury MAN, Chitkara N, Hogdal L, Lindsley CR, Letai A, Itahana K, Bhatt S

TP53 mutations drive therapy resistance through post-mitochondrial caspase blockade.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Cell Death Dis.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title TP53 mutations drive therapy resistance through post-mitochondrial caspase blockade.
Author / Organization Mamdouh AM, Iftikhar F, Olesinski EA, Lim FQ, Jasdanwala S, Wang Y, Mi Y, Lin NSE, Liang DTE, Chowdhury MAN, Chitkara N, Hogdal L, Lindsley CR, Letai A, Itahana K, Bhatt S
Subject & Discipline Cell Death Dis
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-36452
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »